NeoGenomics Sets CEO and Board Succession

Company NeoGenomics Event Type CEO and board succession Modality Oncology diagnostics (laboratory testing, next-generation sequencing) Asset Not applicable Target Not applicable Disease Area Oncology diagnostics Summary Source-gap catch-up for a 5 October announcement. NeoGenomics appointed current president and COO Warren Stone to succeed Tony Zook…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *